Central New York Research Corporation

Syracuse, New York 13210

0 studies enrolling now · 2 studies all time

What they study most

Parkinson's Disease, Recurrent C. Difficile Infection

Studies at this site

• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) — Stopped early
• Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off — Stopped early